Product Information
MUCOSA DM 400-20 MG TABLET is a generic product labeled by Time-Cap Labs Inc., priced at $0.0819 per EA under NDC 49483028006. Its NADAC has been published 547 times since Apr 13, 2016.
Strength
20; 400 mg/1; mg/1
Manufacturer
Time-Cap Labs Inc.NDC
49483028006
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
4/17/2012
Pharmacological Classes
Price Statistics
The NADAC for MUCOSA DM 400-20 MG TABLET has been published 547 times since Apr 13, 2016, and over the history we have for it it has risen 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0819 per EA |
|---|---|
| All-time high | $0.0877 (Aug 12, 2020) |
| All-time low | $0.0720 (May 18, 2022) |
| 52-week high | $0.0819 |
| 52-week low | $0.0779 |
| Median price | $0.0788 |
| Average price | $0.0788 |
| Largest weekly change | +13.7% (Jun 22, 2022) |
| Weeks tracked | 547 |
| Tracking since | Apr 13, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the GUAIFENESIN DEXTROMETHORPHAN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Time-Cap Labs Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
GUAIFENESIN DEXTROMETHORPHAN market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCOSA DM 400-20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MUCOSA DM 400-20 MG TABLET, manufactured by Time-Cap Labs Inc., is $0.0819 per EA (NDC 49483028006), effective Sep 30, 2026.
How has the price of MUCOSA DM 400-20 MG TABLET changed over time?
Over the history we have for it, the NADAC for MUCOSA DM 400-20 MG TABLET has risen 6.2%. It has been tracked across 547 weekly CMS publications since Apr 13, 2016.
What are the highest and lowest recorded NADAC prices for MUCOSA DM 400-20 MG TABLET?
Since Apr 13, 2016, the NADAC for MUCOSA DM 400-20 MG TABLET has ranged from a low of $0.0720 (May 18, 2022) to a high of $0.0877 (Aug 12, 2020), with a median of $0.0788 per EA.
Are there cheaper alternatives to MUCOSA DM 400-20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of MUCOSA DM 400-20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MUCOSA DM 400-20 MG TABLET?
MUCOSA DM 400-20 MG TABLET (NDC 49483028006) is labeled by Time-Cap Labs Inc., and CMS classifies it as a generic product.